National Paediatric Diabetes Audit

{
  "buyer": {
    "id": "GB-PPON-PVVQ-6113-CJWD",
    "name": "Healthcare Quality Improvement Partnership Ltd"
  },
  "date": "2026-03-02T14:38:30Z",
  "id": "018523-2026",
  "initiationType": "tender",
  "language": "en",
  "ocid": "ocds-h6vhtk-065fd2",
  "parties": [
    {
      "address": {
        "country": "GB",
        "countryName": "United Kingdom",
        "locality": "London",
        "postalCode": "EC1V 2NX",
        "region": "UKI43",
        "streetAddress": "128 City Road"
      },
      "contactPoint": {
        "email": "procurement@hqip.org.uk",
        "telephone": "0000000000"
      },
      "details": {
        "classifications": [
          {
            "description": "Public authority - sub-central government",
            "id": "publicAuthoritySubCentralGovernment",
            "scheme": "UK_CA_TYPE"
          }
        ]
      },
      "id": "GB-PPON-PVVQ-6113-CJWD",
      "identifier": {
        "id": "PVVQ-6113-CJWD",
        "scheme": "GB-PPON"
      },
      "name": "Healthcare Quality Improvement Partnership Ltd",
      "roles": [
        "buyer"
      ]
    }
  ],
  "tag": [
    "tender"
  ],
  "tender": {
    "aboveThreshold": true,
    "awardPeriod": {
      "endDate": "2026-10-01T23:59:59+01:00"
    },
    "description": "The contract will initially be delivered for NHS-funded care in England, Wales, and publicly funded care in Jersey for a period of 3 years, at a maximum total budget of up to \u00a31,103,361 including VAT, \u00a31,138,669 excluding VAT. Bids exceeding this limit may be rejected. There is the potential to extend this contract for up to 24 months.\nAll pricing submissions must be in regard to this \u0027core\u0027 value, and not inclusive of any extension costs or aspirational intent costs, i.e. Please only submit a cost schedule up to the maximum core value of \u00a31,103,361 including VAT, \u00a31,138,669 excluding VAT.\nThe maximum budget \u2018core\u2019 value of \u00a31,103,361 including VAT, \u00a31,138,669 excluding VAT excludes the potential two year extension and aspirational intent as described in section 14.4 of Annex A - Service Specification.\nPlease note, there is no commitment by the Authority at this stage to include any aspirational intent measures. Taking the total of this aspirational intent into account, as well as the possibility that a contract extension may be offered for an additional two years, the potential ceiling value is \u00a36,376,600 GBP including VAT, \u00a35,313,917 GBP excluding VAT.\nThe role of a national clinical audit is to stimulate healthcare improvement through the provision of high quality information on the organisation, delivery and outcomes of healthcare, together with tools and support to enable healthcare providers and other audiences to make best use of this information. Outcomes are benchmarked against national guidance and standards e.g. quality standards from the National Institute for Health and Care Excellence (NICE), and those from other established professional and patient sources. Successful national audits are those where the individuals providing the data are also in a position to improve the system, and there is a shared understanding of what good care looks like.\nThe overarching aim is to stimulate improvements in care for children and young people\n(CYP) with paediatric diabetes who receive care from Paediatric Diabetes Units (PDUs),\nby measuring variations in quality, experience and outcomes of NHS care in England and\nWales, and publicly funded care in Jersey. During this contract period, the successful\ntenderer will need to build on the achievements of the audit to date and enhance the\nability for the audit to be used for healthcare improvement.\n*The term CYP (Children and Young People) will be used throughout this notice to refer to\nchildren, adolescents and young people up to 24 years (treated within a Paediatric\nDiabetes Unit (PDU)).\nThis audit programme is expected to:\n\u2022Develop a robust, high-quality audit designed around 10 key quality metrics likely to best support local and national healthcare quality improvement\n\u2022Detect, describe and help reduce unwarranted clinical variation by systematically benchmarking performance, identifying outliers, and supporting services to understand variation in outcomes, processes and experience\n\u2022Achieve, articulate and maintain close alignment with relevant NICE national guidance and quality standards throughout the audit, as appropriate\n\u2022Enable healthcare quality improvement through the provision of timely, high-quality data that compares providers of healthcare, and comprises an integrated mixture of named Trust or Health board, Integrated Care System (ICS), commissioner, multidisciplinary team (MDT), possibly consultant or clinical team level and other levels of reporting\n\u2022Be clinically led\n\u2022Engage patients, carers and the public in a meaningful way, achieving a strong patient voice which informs and contributes to the design, functioning, outputs and direction of the audit\n\u2022Consider the value and feasibility of linking data at an individual patient level to other relevant national datasets either from the outset or in the future, and plan for these linkages from the inception of the contract\n\u2022Ensure robust methodological and statistical input at all stages of the audit\n\u2022Identify from the outset the full range of audiences for the reports and other audit outputs, and plan and tailor them accordingly\n\u2022Provide audit results in a timely, accessible and meaningful manner to support healthcare quality improvement, minimising the reporting delay and providing continual access to each unit for their own data\n\u2022Utilise strong and effective project and programme management to deliver audit outputs on time and within budget\n\u2022Develop and maintain strong engagement with local clinicians, networks, commissioners, patients, their families and carers as well as charity and community support groups to drive improvements in services.\nThe anticipated outputs are:\n\u2022Quarterly interactive metric results\n\u2022Publication of an annual state of the nation report\n\u2022Quality improvement resources \n\u2022The identification and notification of outliers in line with HQIP and provider policies. The provider shall apply the agreed statistical methodology for outlier detection and identify units, ICBs or health boards that demonstrate performance significantly below expected levels on key NPDA indicators.\n\u2022One published spotlight report to be decided by the NPDA dataset and methodology group in conjunction with HQIP and funders\n\u2022One published PREM report to be decided by the NPDA dataset and methodology group in conjunction with HQIP and funder \n\u2022Hybrid closed loop work in collaboration with NHSE HCL implementation plan\nTo respond to this opportunity, please visit https://www.delta-esourcing.com/respond/B249J9GYMY",
    "documents": [
      {
        "description": "Not published",
        "documentType": "conflictOfInterest",
        "id": "conflictOfInterest"
      },
      {
        "documentType": "biddingDocuments",
        "format": "application/vnd.openxmlformats-officedocument.wordprocessingml.document",
        "id": "A-12783",
        "url": "https://www.find-tender.service.gov.uk/Notice/Attachment/A-12783"
      },
      {
        "documentType": "biddingDocuments",
        "format": "application/vnd.openxmlformats-officedocument.wordprocessingml.document",
        "id": "A-12784",
        "url": "https://www.find-tender.service.gov.uk/Notice/Attachment/A-12784"
      },
      {
        "datePublished": "2026-03-02T14:38:30Z",
        "description": "Tender notice on Find a Tender",
        "documentType": "tenderNotice",
        "format": "text/html",
        "id": "018523-2026",
        "noticeType": "UK4",
        "url": "https://www.find-tender.service.gov.uk/Notice/018523-2026"
      }
    ],
    "enquiryPeriod": {
      "endDate": "2026-03-18T12:00:00+00:00"
    },
    "id": "ocds-h6vhtk-065fd2",
    "items": [
      {
        "additionalClassifications": [
          {
            "description": "Health services",
            "id": "85100000",
            "scheme": "CPV"
          }
        ],
        "deliveryAddresses": [
          {
            "country": "GB",
            "countryName": "United Kingdom",
            "region": "UK"
          }
        ],
        "id": "1",
        "relatedLot": "1"
      }
    ],
    "legalBasis": {
      "id": "2023/54",
      "scheme": "UKPGA",
      "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
    },
    "lots": [
      {
        "awardCriteria": {
          "criteria": [
            {
              "description": "500 word count",
              "name": "6.2 Leadership",
              "numbers": [
                {
                  "number": 4,
                  "weight": "percentageExact"
                }
              ],
              "type": "quality"
            },
            {
              "description": "500 word count",
              "name": "6.3 Engaging and Involving Patients , Carers and The Public",
              "numbers": [
                {
                  "number": 8,
                  "weight": "percentageExact"
                }
              ],
              "type": "quality"
            },
            {
              "description": "750 word count",
              "name": "6.4 Stimulating Healthcare Quality Improvement",
              "numbers": [
                {
                  "number": 12,
                  "weight": "percentageExact"
                }
              ],
              "type": "quality"
            },
            {
              "description": "500 word count",
              "name": "6.5 Healthcare Provider Engagement,Participation and Support",
              "numbers": [
                {
                  "number": 5,
                  "weight": "percentageExact"
                }
              ],
              "type": "quality"
            },
            {
              "description": "750 word count",
              "name": "6.6 Data Acquisition Strategy And Burden",
              "numbers": [
                {
                  "number": 12,
                  "weight": "percentageExact"
                }
              ],
              "type": "quality"
            },
            {
              "description": "250 word count",
              "name": "6.7 Information Governance",
              "numbers": [
                {
                  "number": 4,
                  "weight": "percentageExact"
                }
              ],
              "type": "quality"
            },
            {
              "description": "750 word count",
              "name": "6.8 Data Quality and Analysis",
              "numbers": [
                {
                  "number": 12,
                  "weight": "percentageExact"
                }
              ],
              "type": "quality"
            },
            {
              "description": "750 word count",
              "name": "6.9 Uses Of The Data",
              "numbers": [
                {
                  "number": 12,
                  "weight": "percentageExact"
                }
              ],
              "type": "quality"
            },
            {
              "description": "750 word count",
              "name": "6.10 Programme Governance And Delivery Plan",
              "numbers": [
                {
                  "number": 12,
                  "weight": "percentageExact"
                }
              ],
              "type": "quality"
            },
            {
              "description": "250 word count",
              "name": "6.11 risk Management",
              "numbers": [
                {
                  "number": 4,
                  "weight": "percentageExact"
                }
              ],
              "type": "quality"
            },
            {
              "description": "250 word count",
              "name": "6.12. Cost \u0026 Allocation Of Budget",
              "numbers": [
                {
                  "number": 5,
                  "weight": "percentageExact"
                }
              ],
              "type": "price"
            },
            {
              "description": "500 word count",
              "name": "6.13 Social Value",
              "numbers": [
                {
                  "number": 10,
                  "weight": "percentageExact"
                }
              ],
              "type": "quality"
            }
          ]
        },
        "contractPeriod": {
          "endDate": "2030-03-31T23:59:59+00:00",
          "maxExtentDate": "2032-03-31T23:59:59+01:00",
          "startDate": "2027-04-30T00:00:00+01:00"
        },
        "hasRenewal": true,
        "id": "1",
        "renewal": {
          "description": "Up to 24 months"
        },
        "status": "active",
        "suitability": {
          "sme": true,
          "vcse": true
        },
        "value": {
          "amount": 5313917.0,
          "amountGross": 6376700.0,
          "currency": "GBP"
        }
      }
    ],
    "mainProcurementCategory": "services",
    "procurementMethod": "open",
    "procurementMethodDetails": "Open procedure",
    "riskDetails": "Full details of the aspirational intent and its mechanisms for invoking as well as potential maximum value are listed in Annex A - Service Specification. The below is a summary of the potential measures that may risk service delivery and are at the funders discretion.\n1. Up to 24-month extension that mirrors the NCAPOP headline contract - Up to \u00a3884,977 inclusive of VAT\n2. Inclusion of additional similar clinical audits and/or Clinical Outcome Review Programmes (CORP)- Up to\n \u00a3720,000\n3. Transition to different models of data collection/outputs \u0026/or operational methods/processes for the audit. This may include implementing new ways of working where opportunities emerge to leverage artificial intelligence tools to drive efficiency and reduce burden -Up to\n\u00a3720,000\n4. Extending specific service coverage to include privately funded care - Up to\n \u00a31,200,000\n5. Additions or enhancements to the service delivery of the project - Up to\n\u00a31,200,000\n6. Changes in line with national policy - Up to\n \u00a31,200,000\n7. Additional quality improvement initiatives either related to or linked with the project - Up to\n\u00a3360,000\n8. Inclusion of additional national or international funders - Up to\n\u00a3699,538\n9. Data visibility - Up to\n\u00a3360,000",
    "status": "active",
    "submissionMethodDetails": "https://www.delta-esourcing.com/respond/B249J9GYMY",
    "submissionTerms": {
      "electronicSubmissionPolicy": "allowed",
      "languages": [
        "en"
      ]
    },
    "tenderPeriod": {
      "endDate": "2026-04-01T12:00:00+01:00"
    },
    "title": "National Paediatric Diabetes Audit",
    "value": {
      "amount": 5313917.0,
      "amountGross": 6376700.0,
      "currency": "GBP"
    }
  }
}